These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 2991571)
1. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. Para MF; Parish ML; Noble AG; Spear PG J Virol; 1985 Aug; 55(2):483-8. PubMed ID: 2991571 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to herpes simplex virus type 1 glycoproteins show that epitope location influences virus neutralization. La Thangue NB; Chan WL; Almeida JD J Med Virol; 1984; 13(3):227-42. PubMed ID: 6202837 [TBL] [Abstract][Full Text] [Related]
3. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge. Roberts PL; Duncan BE; Raybould TJ; Watson DH J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080 [TBL] [Abstract][Full Text] [Related]
4. Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. Fuller AO; Spear PG J Virol; 1985 Aug; 55(2):475-82. PubMed ID: 2991570 [TBL] [Abstract][Full Text] [Related]
5. Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. Highlander SL; Sutherland SL; Gage PJ; Johnson DC; Levine M; Glorioso JC J Virol; 1987 Nov; 61(11):3356-64. PubMed ID: 2444713 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies directed against a 130K glycoprotein of bovine herpesvirus 2 cross-react with glycoprotein B of herpes simplex virus. Conraths FJ; Pauli G; Ludwig H Virus Res; 1988 Apr; 10(1):53-63. PubMed ID: 2837013 [TBL] [Abstract][Full Text] [Related]
7. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583 [TBL] [Abstract][Full Text] [Related]
8. Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. Para MF; Zezulak KM; Conley AJ; Weinberger M; Snitzer K; Spear PG J Virol; 1983 Mar; 45(3):1223-7. PubMed ID: 6300459 [TBL] [Abstract][Full Text] [Related]
9. Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Rector JT; Lausch RN; Oakes JE Infect Immun; 1982 Oct; 38(1):168-74. PubMed ID: 6292092 [TBL] [Abstract][Full Text] [Related]
10. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. Fuller AO; Santos RE; Spear PG J Virol; 1989 Aug; 63(8):3435-43. PubMed ID: 2545914 [TBL] [Abstract][Full Text] [Related]
11. The use of monoclonal antibodies in (reverse) passive haemagglutination tests for herpes simplex virus antigens and antibodies. Cranage MP; McLean CS; Buckmaster EA; Minson AC; Wildy P; Coombs RR J Med Virol; 1983; 11(4):295-306. PubMed ID: 6308140 [TBL] [Abstract][Full Text] [Related]
12. Neutralizing activity of antibodies against the major herpes simplex virus type 1 glycoproteins. Eing BR; Kühn JE; Braun RW J Med Virol; 1989 Jan; 27(1):59-65. PubMed ID: 2466100 [TBL] [Abstract][Full Text] [Related]
13. Competitive inhibition by human sera of mouse monoclonal antibody binding to glycoproteins C and D of herpes simplex virus types 1 and 2. Ross C; Glorioso J; Sacks S; Lavery C; Rawls WE J Virol; 1985 Jun; 54(3):851-5. PubMed ID: 2582149 [TBL] [Abstract][Full Text] [Related]
14. Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Balachandran N; Bacchetti S; Rawls WE Infect Immun; 1982 Sep; 37(3):1132-7. PubMed ID: 6290390 [TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. Kari B; Lussenhop N; Goertz R; Wabuke-Bunoti M; Radeke R; Gehrz R J Virol; 1986 Nov; 60(2):345-52. PubMed ID: 3021969 [TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein. Edson CM; Hosler BA; Respess RA; Waters DJ; Thorley-Lawson DA J Virol; 1985 Oct; 56(1):333-6. PubMed ID: 2993665 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of monoclonal antibodies and immunopurified glycoproteins in primary HSV-1 infection. Lukic ML; Liew FY; Chan WL Adv Exp Med Biol; 1985; 186():855-61. PubMed ID: 2996318 [No Abstract] [Full Text] [Related]
18. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization. Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against herpes simplex viruses. Scheffer AJ; Koedijk DG; Abee T; Osterhaus AD Dev Biol Stand; 1984; 57():269-74. PubMed ID: 6098497 [TBL] [Abstract][Full Text] [Related]
20. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. Chan WL; Lukig ML; Liew FY J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]